Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $4.21M in the quarter ending March 31, 2026, a decrease of -95.04%. This brings the company's revenue in the last twelve months to $42.95M, down -73.07% year-over-year. In the year 2025, Monte Rosa Therapeutics had annual revenue of $123.67M with 63.54% growth.

• Revenue (ttm): $42.95M
• Revenue Growth: -73.07%
• P/S Ratio: 36.01
• Revenue / Employee: $229,695
• Employees: 187
• Market Cap: 1.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	123.67M	48.05M	63.54%
Dec 31, 2024	75.62M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error